CombinedClosedNo Set aside used1View procurement thread

Advanced Manufacturing Technologies In-Person Training Programview on SAM.gov

HEALTH AND HUMAN SERVICES, DEPARTMENT OF › FDA CENTER FOR DRUG EVALUATION AND RESEARCH

Posted Jul 23, 2026

Due Aug 4, 2026

Silver Spring, MD

NAICS 813920 – Professional Organizations

Sol # FDA-26-PWS-135129

AI Summary

• The pharmaceutical industry is undergoing a significant technological shift in production due to new capabilities such as continuous manufacturing, additive manufacturing.
• This innovation offers increased flexibility for production and enhanced resilience within complex global supply chains.
• Such technologies would enable more precise control over the manufacturing process.
• Increased use of 3D-printing technology provides better product consistency.
• Adoption of cloud-based platforms can improve global supply chain efficiency.

Description

Requiring training in advanced manufacturing technologies — including continuous manufacturing, additive manufacturing, along with platform and modular technologies — represent a significant evolution in pharmaceutical production. These technologies offer the potential to increase manufacturing flexibility and strengthen supply chain resilience.

Classification

NAICS813920

PSC CodeAN21

Place of Performance

CitySilver Spring

StateMD

CountryUNITED STATES

Contracting Office

OfficeFDA CENTER FOR DRUG EVALUATION AND RESEARCH

CitySilver Spring

StateMD

ZIP20993